American College of Clinical Pharmacology

ACCP seeks qualified applicants for the position of Editor-in-Chief of the Clinical Pharmacology in Drug Development (CPDD).

To view the job description and request for applications please visit
https://bit.ly/4bMi2h8

The due date for applications is September 20, 2024.

The CPDD is one of the two official publications of the ACCP and is an international, peer-reviewed journal focused on publishing high-quality clinical pharmacology studies in drug development which are primarily (but not exclusively) performed in healthy subjects during the early phases of drug development, or after marketing approval. Acceptance of a manuscript in CPDD is determined by scientific rigor and technical soundness rather than perceived importance of the presented results. In addition to publication of original research articles, CPDD encourages submission (with or without invitation) of Editorials, Commentaries and Reviews.

Since its introduction in 2012, CPDD has included an international Editorial Board consisting of basic and clinical scientists who are well-established in the field of clinical pharmacology and represent academic, regulatory and industry sectors. The Editorial Board works closely with the Editor-in-Chief to provide strategic oversight and guidance, as well as to assist with operational requirements.

The CPDD is published by Wiley Periodicals Inc, a subsidiary of John Wiley & Sons Inc (Publisher).

We encourage you to share this with qualified colleagues who may wish to apply.

American College of Clinical Pharmacology® is currently seeking nominations for the 2025 ACCP Honors & Awards Program! Help ACCP recognize your colleague for their exceptional contribution to the field of clinical pharmacology by submitting a nomination today. Awards will be presented at the 2025 ACCP Annual Meeting, September 14-16, 2025 in Phoenix, AZ.

https://bit.ly/3SIwEre

Submit your nomination before the deadline of November 30, 2024!

The ACCP Honors & Awards Committee is currently accepting nominations for the following 2025 ACCP Recognition Awards:

2025 ACCP Distinguished Investigator Award
2025 ACCP Honorary Fellowship Award
2025 Nathaniel T. Kwit Memorial Distinguished Service Award
2025 Roger Jelliffe Individualized Therapy Award
2025 Hartmut Derendorf Mentorship in Clinical Pharmacology Award
2025 Tanabe Young Investigator Award
2025 McKeen Cattell Memorial Award (Nominations for the McKeen Cattell Award are selected by the editors of The Journal of Clinical Pharmacology and the ACCP Honors & Awards Committee)

The Clinical Pharmacology Review Course

https://lnkd.in/eUiYFVkn

The Clinical Pharmacology Review Course is presented by ACCP and the American Board of Clinical Pharmacology to provide a comprehensive review of topics of broad interest to clinical pharmacologists. The Course will combine presentation of new developments in clinical pharmacology as a method for review of topics associated with the core concepts in clinical pharmacology. The Course format will be didactic sessions, focusing on core knowledge areas in clinical pharmacology and include clinical management case discussion to enhance problem-solving skills in a format commonly used in board examinations. Content begins with four talks to highlight the fundamental principles of pharmacokinetics and pharmacodynamics and their therapeutic applications to special populations. The remainder of the course includes six talks in selected clinical therapeutic areas that apply the fundamental principles to clinical decision-making for the clinically-minded MD, PharmD or PhD scientist.

https://lnkd.in/eUiYFVkn

Also, Don't forget to register for:

2024 ACCP Trends in Drug Development Seminar

&

Physiologically-based Pharmacokinetic Analyses: Practical Applications in Clinical Drug Development

The American College of Clinical Pharmacology® (ACCP) is pleased to announce the publication of "Unregulated Psychotropic Products" in the August 2024 issue of ACCP's The Journal of Clinical Pharmacology.https://files.constantcontact.com/418eef03101/d4c134fe-6496-4112-8bb6-fc23b5e9f8d5.pdf

ACCP offers free CME and CPE credits to Members each month for a selected article in The Journal of Clinical Pharmacology! Non-members may obtain CE credits by accessing an entire year's worth of articles for the one-time fee of $75. https://bit.ly/3TSGkAF

2024 ACCP Trends in Drug Development Seminar

https://lnkd.in/eUiYFVkn

Discover the Future of Clinical Pharmacology: Trends in Drug Development Seminar. Join us for an insightful journey into current trends in drug development. This four-session seminar offers a comprehensive view of cutting-edge research and developments, with a focus on practical applications and the evolving landscape of clinical pharmacology.

Session 1: Broadening Naloxone Accessibility
Delve into the US regulatory strategy that brought the first over-the-counter naloxone product to market. Explore the innovative use of pharmacokinetic/pharmacodynamic (PK/PD) translational models to implement safe opioid antagonist formulations and dosing strategies. Engage in discussions about the community impact and opportunities to expand accessibility through specific formulations.

Session 2: Expanding mRNA-Based Therapies
Uncover the pivotal role of clinical pharmacology driving mRNA-based therapies for critical health conditions. Learn how model-informed decision-making is expanding the therapeutic possibilities of this novel platform, transforming the clinical landscape across diverse therapeutic areas beyond vaccines.

Session 3: Drug Safety and Aging
Join a robust discussion on the unique considerations of drug safety and efficacy in aging populations. Focus on specific drug classes where age is a critical factor and explore opportunities for model-informed precision dosing within the current US regulatory framework.

Session 4: AI in Drug Development
Explore the transformative role of Artificial Intelligence in drug development. Discover how AI is reshaping the landscape, from early-stage research to clinical trials, and unlocking new possibilities for innovation and efficiency.

Don't miss this opportunity to stay ahead of the curve and enhance your expertise in the dynamic field of clinical pharmacology. Register now to secure your spot!

Also, Don't forget to register for:

Clinical Pharmacology Review Course
Hosted by ACCP & ABCP

&

Physiologically-based Pharmacokinetic Analyses: Practical Applications in Clinical Drug Development

JUST 48 HOURS LEFT!
DEADLINE JULY 31st

The Call for Proposals Submission System for the 2025 Annual Meeting of the American College of Clinical Pharmacology® (ACCP) is now open!

https://www.abstractscorecard.com/cfp/submit/login.asp?EventKey=EMJPPYSH

The 2025 ACCP Annual Meeting, "Leveraging Innovative Approaches to Transform Clinical Pharmacology" will provide a forum for discussion on important clinical pharmacology topics ranging from research and drug discovery to patient care. Submit a Proposal through ACCP's online Submission System in the link above.
For each Proposal submitted, the submitter and at least one (1) Session Co-chair must be a current Member of ACCP at the time of submission and at the time of the ACCP Annual Meeting in which the event will be held. If you are not a current ACCP Member, visit the Join webpage to apply for or renew your membership.
The submission deadline is July 31, 2024!

https://www.abstractscorecard.com/cfp/submit/login.asp?EventKey=EMJPPYSH

Check out the ACCP Job Ctr for current job listings and find your ideal opportunity!
https://bit.ly/48yxywv

Vikram Arya PhD, FCP to serve as Councilor on ACCP Executive Committee 2024-2026.
https://accp1.org/common/Uploaded%20files/documents/annualmeeting/2024/2024%20ACCP%20Nathaniel%20T%20Kwit%20Memorial%20Distinguished%20Service%20Award%20BIO.pdf

JUST 1 WEEK LEFT!
DEADLINE JULY 31st
The Call for Proposals Submission System for the 2025 Annual Meeting of the American College of Clinical Pharmacology® (ACCP) is now open!

https://www.abstractscorecard.com/cfp/submit/login.asp?EventKey=EMJPPYSH

The 2025 ACCP Annual Meeting, "Leveraging Innovative Approaches to Transform Clinical Pharmacology" will provide a forum for discussion on important clinical pharmacology topics ranging from research and drug discovery to patient care. Submit a Proposal through ACCP's online Submission System in the link above.
For each Proposal submitted, the submitter and at least one (1) Session Co-chair must be a current Member of ACCP at the time of submission and at the time of the ACCP Annual Meeting in which the event will be held. If you are not a current ACCP Member, visit the Join webpage to apply for or renew your membership.
The submission deadline is July 31, 2024!

https://www.abstractscorecard.com/cfp/submit/login.asp?EventKey=EMJPPYSH

The ACCP “Excellence in Achievement” Program is pleased to recognize Karthik Venkatakrishnan, PhD, FCP.

Dr. Venkatakrishnan joined ACCP in 2013 and has served on the Credentials Committee, the Working Group on Fellow Requirements and is an active contributor on the Public Policy Committee. He has published numerous manuscripts in ACCP journals, serves on the Editorial Board of The Journal of Clinical Pharmacology and Clinical Pharmacology in Drug Development and is also an ACCP New Member Ambassador. He encourages membership in the society through the Member-Get-a-Member Program, plus has submitted educational Proposals and nominations for the ACCP Recognition Awards Program. He is a regular attendee of the ACCP Annual Meeting, where he has participated as a Faculty Speaker, Poster presenter and STEP & ESP Panelist. In 2023, he presented a webinar to young colleagues sharing his wisdom on career resilience and tools to thrive through challenges.

ACCP is pleased to present the Quarterly report for Q2 2024.
Read more about our milestone achievements and operational activities!
https://accp1.org/common/Uploaded%20files/pdfs/documents/Committee%20Charters/ACCP%20Quarterly%20Report%20Q2%202024_2024%20July.pdf

ACCP offers free CME and CPE credits to Members each month for a selected article in The Journal of Clinical Pharmacology! Non-members may obtain CE credits by accessing an entire year's worth of articles for the one-time fee of $75. https://lnkd.in/evBaZ5E4

ACCP seeks qualified applicants for the position of Editor-in-Chief of the Clinical Pharmacology in Drug Development (CPDD)

To view the job description and request for applications please visit
https://accp1.org/ACCP1/5Publications_and_News/Copy_of_CPDD-Editor-in-Chief-Position.aspx

The due date for applications is September 20, 2024.

The CPDD is one of the two official publications of the ACCP and is an international, peer-reviewed journal focused on publishing high-quality clinical pharmacology studies in drug development which are primarily (but not exclusively) performed in healthy subjects during the early phases of drug development, or after marketing approval. Acceptance of a manuscript in CPDD is determined by scientific rigor and technical soundness rather than perceived importance of the presented results. In addition to publication of original research articles, CPDD encourages submission (with or without invitation) of Editorials, Commentaries and Reviews.

Since its introduction in 2012, CPDD has included an international Editorial Board consisting of basic and clinical scientists who are well-established in the field of clinical pharmacology and represent academic, regulatory and industry sectors. The Editorial Board works closely with the Editor-in-Chief to provide strategic oversight and guidance, as well as to assist with operational requirements.

The CPDD is published by Wiley Periodicals Inc, a subsidiary of John Wiley & Sons Inc (Publisher).

We encourage you to share this with qualified colleagues who may wish to apply.

Clinical Pharmacology in Drug Development (CPDD) is an international, peer-reviewed, online publication of the ACCP focused on publishing high-quality clinical pharmacology studies in drug development. https://bit.ly/39XjxMS Wiley Clinical Health

STEP & ESP Events, Plenary Session & Invited Keynote!

2024 ACCP Annual Meeting

https://lnkd.in/eUiYFVkn

A series of Student, Trainee & Early-stage Professional (STEP) and Early-stage Professional (ESP) events will provide career guidance and an opportunity to network with leaders in the clinical pharmacology field. STEP & ESP events are made available at no cost to all STEP & ESP Attendees.

STEP & ESP Attendees may also find the Pre-meeting Workshop on September 7th, Physiologically-based Pharmacokinetic Analyses: Practical Applications in Clinical Drug Development, of interest. This is a must-attend event if you are interested in enhancing your skills in applying state-of-the-art data and pharmacometrics analysis methods in drug development and patient care.

The Plenary Session will take place on Sunday, September 8, 2024 at 8:00 AM EST and will feature Faculty Speakers Qi Liu, PhD & Jogarao V. Gobburu, PhD, MBA

Drs. Liu and Gobburu will discuss how Artificial Intelligence/Machine Learning (AI/ML) can be applied to healthcare in general and clinical pharmacology’s role in drug development specifically. The two presentations in this session will provide applications and utilizations of AI/ML from the perspectives of both industry/academia and regulatory. The first presentation will explore how AI is revolutionizing healthcare through its applications in medical imaging, treatment optimization and dose optimization along with the ethical considerations of this approach and define clinical pharmacology’s role. The second presentation will provide an overview of AI/ML applications toward drug development from a regulatory perspective, including how regulators are utilizing AI/ML themselves to expedite submission review.

Invited Keynote Speaker

Jack Yanovski, MD, PhD

ACCP is pleased to announce Jack Yanovski MD, PhD, Chief of the Section on Growth & Obesity and Associate Scientific Director for Translational Medicine in the Eunice Kennedy Shriver National Inst of Child Health & Human Development of the National Inst of Health (NIH). Dr. Yanovski obtained his MD and PhD degrees at the Univ of Pennsylvania, completed residency training in Pediatrics at the Children’s Hosp of Philadelphia and fellowship training in Pediatric Endocrinology at NIH. The Invited Keynote address will take place on Monday, September 9, 2024 at 10:30 AM

JUST 3 WEEKS LEFT!
DEADLINE JULY 31st
The Call for Proposals Submission System for the 2025 Annual Meeting of the American College of Clinical Pharmacology® (ACCP) is now open!

https://bitly.com/ # #

The 2025 ACCP Annual Meeting, "Leveraging Innovative Approaches to Transform Clinical Pharmacology" will provide a forum for discussion on important clinical pharmacology topics ranging from research and drug discovery to patient care. Submit a Proposal through ACCP's online Submission System in the link above.

For each Proposal submitted, the submitter and at least one (1) Session Co-chair must be a current Member of ACCP at the time of submission and at the time of the ACCP Annual Meeting in which the event will be held. If you are not a current ACCP Member, visit the Join webpage to apply for or renew your membership.

The submission deadline is July 31, 2024! https://bitly.com/ # #

Check out the ACCP Job Ctr for current job listings and find your ideal opportunity!

https://bit.ly/48yxywv

Just 48 hours left until Early-bird registration ends June 30th for the 2024 ACCP Annual Meeting "Transformative Solutions: Delivering on the Promise of Clinical Pharmacology for Patient Care," which will be held on September 8 – 10, 2024 at the Bethesda N Marriott Hotel & Conference Ctr in N Bethesda, MD.

https://lnkd.in/eUiYFVkn

The 2024 Annual Meeting Program Committee, co-chaired by Drs. Catherijne Knibbe and Amit Pai, has worked diligently to prepare an educational program of transformative science that meets the needs of healthcare professionals and scientists with an interest in one or more of the myriad of applications of clinical pharmacology including all stages of drug development research and optimizing patient care. The 3-day meeting will include many of the elements you have come to appreciate in the ACCP Annual Meeting:

17 Outstanding educational Symposia, including three Hot Topic Sessions a Plenary Session & the Invited Keynote
2024 Trends in Drug Development Seminar on cutting-edge topics in preclinical and clinical drug development
Pre-meeting Workshop on Physiologically-based Pharmacokinetics Analyses: Practical Applications in Clinical Drug Development
A series of exceptional events focused around Students, Trainees & Early-stage Professionals
Clinical Pharmacology Review Course, Hosted by ACCP & ABCP
2024 ACCP Recognition Award Winner presentations & interviews during Lunch & Awards
Evening Receptions on Sunday & Monday where Attendees can socialize & network, explore scientific Posters and meet with our valued Exhibitors

View Early-bird registration rates and Register today and get the benefit of Early Bird registration fees that end June 30th.

The Early-bird 3-day Registration is priced at $1,080 for ACCP Members, $1,800 for Non-members, $425 for Student Members and $585 for Student Non-members. Register by June 30th to take advantage of these discounted rates. ACCP is pleased to offer special registration rates to Students & Trainees, colleagues from US government entities and those currently residing in developing countries. CME & CPE Credits will be offered at no additional cost to Attendees.

DEADLINE JULY 31st

The Call for Proposals Submission System for the 2025 Annual Meeting of the American College of Clinical Pharmacology® (ACCP) is now open!

https://lnkd.in/eQzyyG_C

The 2025 ACCP Annual Meeting, "Leveraging Innovative Approaches to Transform Clinical Pharmacology" will provide a forum for discussion on important clinical pharmacology topics ranging from research and drug discovery to patient care. Submit a Proposal through ACCP's online Submission System in the link above.

For each Proposal submitted, the submitter and at least one (1) Session Co-chair must be a current Member of ACCP at the time of submission and at the time of the ACCP Annual Meeting in which the event will be held. If you are not a current ACCP Member, visit the Join webpage to apply for or renew your membership.

The submission deadline is July 31, 2024! https://lnkd.in/eQzyyG_C

Just 5 days left until Early-bird registration ends June 30th for the 2024 ACCP Annual Meeting "Transformative Solutions: Delivering on the Promise of Clinical Pharmacology for Patient Care," which will be held on September 8 – 10, 2024 at the Bethesda N Marriott Hotel & Conference Ctr in N Bethesda, MD.

https://lnkd.in/eUiYFVkn

The 2024 Annual Meeting Program Committee, co-chaired by Drs. Catherijne Knibbe and Amit Pai, has worked diligently to prepare an educational program of transformative science that meets the needs of healthcare professionals and scientists with an interest in one or more of the myriad of applications of clinical pharmacology including all stages of drug development research and optimizing patient care. The 3-day meeting will include many of the elements you have come to appreciate in the ACCP Annual Meeting:

17 Outstanding educational Symposia, including three Hot Topic Sessions, a Plenary Session & the Invited Keynote

2024 Trends in Drug Development Seminar on cutting-edge topics in preclinical and clinical drug development

Pre-meeting Workshop on Physiologically-based Pharmacokinetics Analyses: Practical Applications in Clinical Drug Development

A series of exceptional events focused around Students, Trainees & Early-stage Professionals

Clinical Pharmacology Review Course, Hosted by ACCP & ABCP

2024 ACCP Recognition Award Winner presentations & interviews during Lunch & Awards

Evening Receptions on Sunday & Monday where Attendees can socialize & network, explore scientific Posters and meet with our valued Exhibitors

View Early-bird registration rates and Register today and get the benefit of Early Bird registration fees that end June 30th.

The Early-bird 3-day Registration is priced at $1,080 for ACCP Members, $1,800 for Non-members, $425 for Student Members and $585 for Student Non-members. Register by June 30th to take advantage of these discounted rates. ACCP is pleased to offer special registration rates to Students & Trainees, colleagues from US government entities and those currently residing in developing countries. CME & CPE Credits will be offered at no additional cost to Attendees.

Just 10 days left until Early-bird registration ends June 30th for the 2024 ACCP Annual Meeting "Transformative Solutions: Delivering on the Promise of Clinical Pharmacology for Patient Care," which will be held on September 8 – 10, 2024 at the Bethesda N Marriott Hotel & Conference Ctr in N Bethesda, MD.

https://lnkd.in/eUiYFVkn

The 2024 Annual Meeting Program Committee, co-chaired by Drs. Catherijne Knibbe and Amit Pai, has worked diligently to prepare an educational program of transformative science that meets the needs of healthcare professionals and scientists with an interest in one or more of the myriad of applications of clinical pharmacology including all stages of drug development research and optimizing patient care. The 3-day meeting will include many of the elements you have come to appreciate in the ACCP Annual Meeting:

17 Outstanding educational Symposia, including three Hot Topic Sessions a Plenary Session & the Invited Keynote

2024 Trends in Drug Development Seminar on cutting-edge topics in preclinical and clinical drug development

Pre-meeting Workshop on Physiologically-based Pharmacokinetics Analyses: Practical Applications in Clinical Drug Development

A series of exceptional events focused around Students, Trainees & Early-stage Professionals

Clinical Pharmacology Review Course, Hosted by ACCP & ABCP

2024 ACCP Recognition Award Winner presentations & interviews during Lunch & Awards

Evening Receptions on Sunday & Monday where Attendees can socialize & network, explore scientific Posters and meet with our valued Exhibitors

View Early-bird registration rates and Register today and get the benefit of Early Bird registration fees that end June 30th.

The Early-bird 3-day Registration is priced at $1,080 for ACCP Members, $1,800 for Non-members, $425 for Student Members and $585 for Student Non-members. Register by June 30th to take advantage of these discounted rates. ACCP is pleased to offer special registration rates to Students & Trainees, colleagues from US government entities and those currently residing in developing countries. CME & CPE Credits will be offered at no additional cost to Attendees.

The Call for Proposals Submission System for the 2025 Annual Meeting of the American College of Clinical Pharmacology® (ACCP) is now open!

https://lnkd.in/eQzyyG_C

The 2025 ACCP Annual Meeting, "Leveraging Innovative Approaches to Transform Clinical Pharmacology" will provide a forum for discussion on important clinical pharmacology topics ranging from research and drug discovery to patient care. Submit a Proposal through ACCP's online Submission System in the link above.

For each Proposal submitted, the submitter and at least one (1) Session Co-chair must be a current Member of ACCP at the time of submission and at the time of the ACCP Annual Meeting in which the event will be held. If you are not a current ACCP Member, visit the Join webpage to apply for or renew your membership.

The submission deadline is July 31, 2024! https://lnkd.in/eQzyyG_C

Register Now for the June 2024 ACCP Virtual Journal Club Webinar: Estimation of Absolute and Relative Body Fat Content Using Noninvasive Surrogates: Can DXA Be Bypassed?

https://lnkd.in/ecg9uEZB

Why is this article important to your practice?

This study explores innovative methods to predict body fat content using easily measurable anthropometric variables like age, height, weight and waist circumference instead of relying on the expensive and less accessible dual-energy x-ray absorptiometry (DXA) scanning. This research is crucial as it provides an improved and validated algorithm for predicting absolute body fat, which can enhance clinical practices related to obesity management. Understanding these new predictive methods can directly impact practice, especially considering the critical role that body composition plays in pharmacokinetics and pharmacodynamics. Efficient and accurate body fat estimation methods are essential for optimizing drug dosing and therapeutic strategies in obese patients, thereby improving treatment outcomes and patient care. Learners that complete this activity will be provided an evidence-based, validated and predictive algorithm as an alternative to DXA scanning to accurately estimate absolute body fat.

Target Audience:

Interprofessional team of Physicians, Pharmacists, PhDs, Nurse Practitioners and other health care professionals who use the assessment of body fat content in clinical trials and clinical practice.

Learning Objectives

After completing this activity, the learner will be able to:
Describe at least one limitation to the use of DXA scanning for obesity clinical trials and/or drug development;
Identify at least one DXA-determined measurement that was selected as a dependent (outcome) variable in this study;
List at least one surrogate variable that was predictive of DXA-determined absolute body fat; Identify which surrogate variable had the greatest impact (i.e., magnitude of change) on DXA-determined total body fat in men and women utilizing standardized regression coefficient data.

ACCP has a variety of Live, On Demand and text-based online CE resources available for completion for your professional development. Visit ACCP Continuing Education to learn more or select from any of the On Demand courses bit.ly/3FBV1zD

Don't Forget to Register!

Clinical Pharmacology Review Course,

Pre-meeting Workshop &

Trends in Drug Development

https://accp1.org/ACCP1/Events/Event_Display.aspx?EventKey=2024AM

Clinical Pharmacology Review Course
Hosted by ACCP & ABCP
Wednesday, September 11th | 8:00 AM – 5:00 PM ET | CE: 6

Physiologically-based Pharmacokinetic Analyses:
Practical Applications in Clinical Drug Development
Saturday, September 7th | 8:00 AM – 5:00 PM ET | CE: 6

2024 ACCP Trends in Drug Development Seminar
Saturday, September 7th | 8:00 AM – 5:00 PM | CE: 6

ACCP is accredited by the ACCME & ACPE and offers CME & CPE credits for all events at no extra cost.